156 related articles for article (PubMed ID: 29367212)
1. Impact of Cardiac Progenitor Cells on Heart Failure and Survival in Single Ventricle Congenital Heart Disease.
Sano T; Ousaka D; Goto T; Ishigami S; Hirai K; Kasahara S; Ohtsuki S; Sano S; Oh H
Circ Res; 2018 Mar; 122(7):994-1005. PubMed ID: 29367212
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary Cardiac Progenitor Cells in Single Ventricle Physiology: The PERSEUS (Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease) Randomized Phase 2 Trial.
Ishigami S; Ohtsuki S; Eitoku T; Ousaka D; Kondo M; Kurita Y; Hirai K; Fukushima Y; Baba K; Goto T; Horio N; Kobayashi J; Kuroko Y; Kotani Y; Arai S; Iwasaki T; Sato S; Kasahara S; Sano S; Oh H
Circ Res; 2017 Mar; 120(7):1162-1173. PubMed ID: 28052915
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.
Ishigami S; Ohtsuki S; Tarui S; Ousaka D; Eitoku T; Kondo M; Okuyama M; Kobayashi J; Baba K; Arai S; Kawabata T; Yoshizumi K; Tateishi A; Kuroko Y; Iwasaki T; Sato S; Kasahara S; Sano S; Oh H
Circ Res; 2015 Feb; 116(4):653-64. PubMed ID: 25403163
[TBL] [Abstract][Full Text] [Related]
4. Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial.
Tarui S; Ishigami S; Ousaka D; Kasahara S; Ohtsuki S; Sano S; Oh H
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1198-1207, 1208.e1-2. PubMed ID: 26232942
[TBL] [Abstract][Full Text] [Related]
5. Reverse electrical remodeling in rats with heart failure and preserved ejection fraction.
Cho JH; Kilfoil PJ; Zhang R; Solymani RE; Bresee C; Kang EM; Luther K; Rogers RG; de Couto G; Goldhaber JI; Marbán E; Cingolani E
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282820
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic cardiosphere-derived cells for the treatment of heart failure with reduced ejection fraction: the Dilated cardiomYopathy iNtervention with Allogeneic MyocardIally-regenerative Cells (DYNAMIC) trial.
Chakravarty T; Henry TD; Kittleson M; Lima J; Siegel RJ; Slipczuk L; Pogoda JM; Smith RR; Malliaras K; Marbán L; Ascheim DD; Marbán E; Makkar RR
EuroIntervention; 2020 Jul; 16(4):e293-e300. PubMed ID: 31763984
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
8. Cardiosphere-derived cells improve function in the infarcted rat heart for at least 16 weeks--an MRI study.
Carr CA; Stuckey DJ; Tan JJ; Tan SC; Gomes RS; Camelliti P; Messina E; Giacomello A; Ellison GM; Clarke K
PLoS One; 2011; 6(10):e25669. PubMed ID: 22043289
[TBL] [Abstract][Full Text] [Related]
9. Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction.
Kanazawa H; Tseliou E; Dawkins JF; De Couto G; Gallet R; Malliaras K; Yee K; Kreke M; Valle I; Smith RR; Middleton RC; Ho CS; Dharmakumar R; Li D; Makkar RR; Fukuda K; Marbán L; Marbán E
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857066
[TBL] [Abstract][Full Text] [Related]
10. Lack of Cardiac Improvement After Cardiosphere-Derived Cell Transplantation in Aging Mouse Hearts.
Zhao ZA; Han X; Lei W; Li J; Yang Z; Wu J; Yao M; Lu XA; He L; Chen Y; Zhou B; Hu S
Circ Res; 2018 Oct; 123(10):e21-e31. PubMed ID: 30359191
[TBL] [Abstract][Full Text] [Related]
11. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.
Assmus B; Walter DH; Seeger FH; Leistner DM; Steiner J; Ziegler I; Lutz A; Khaled W; Klotsche J; Tonn T; Dimmeler S; Zeiher AM
JAMA; 2013 Apr; 309(15):1622-31. PubMed ID: 23592107
[TBL] [Abstract][Full Text] [Related]
12. Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case-control study.
Liu M; Fang F; Luo XX; Shlomo BH; Burkhoff D; Chan JY; Chan CP; Cheung L; Rousso B; Gutterman D; Yu CM
Int J Cardiol; 2016 Mar; 206():122-6. PubMed ID: 26788686
[TBL] [Abstract][Full Text] [Related]
13. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction.
Lee ST; White AJ; Matsushita S; Malliaras K; Steenbergen C; Zhang Y; Li TS; Terrovitis J; Yee K; Simsir S; Makkar R; Marbán E
J Am Coll Cardiol; 2011 Jan; 57(4):455-65. PubMed ID: 21251587
[TBL] [Abstract][Full Text] [Related]
14. Age-Dependent Effect of Pediatric Cardiac Progenitor Cells After Juvenile Heart Failure.
Agarwal U; Smith AW; French KM; Boopathy AV; George A; Trac D; Brown ME; Shen M; Jiang R; Fernandez JD; Kogon BE; Kanter KR; Alsoufi B; Wagner MB; Platt MO; Davis ME
Stem Cells Transl Med; 2016 Jul; 5(7):883-92. PubMed ID: 27151913
[TBL] [Abstract][Full Text] [Related]
15. Fibrosis-Related Gene Expression in Single Ventricle Heart Disease.
Nakano SJ; Siomos AK; Garcia AM; Nguyen H; SooHoo M; Galambos C; Nunley K; Stauffer BL; Sucharov CC; Miyamoto SD
J Pediatr; 2017 Dec; 191():82-90.e2. PubMed ID: 29050751
[TBL] [Abstract][Full Text] [Related]
16. Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival: Results From the Valsartan Heart Failure Trial.
Florea VG; Rector TS; Anand IS; Cohn JN
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413037
[TBL] [Abstract][Full Text] [Related]
17. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917
[TBL] [Abstract][Full Text] [Related]
18. Repeated cell transplantation and adjunct renal denervation in ischemic heart failure: exploring modalities for improving cell therapy efficacy.
Polhemus DJ; Trivedi RK; Sharp TE; Li Z; Goodchild TT; Scarborough A; de Couto G; Marbán E; Lefer DJ
Basic Res Cardiol; 2019 Jan; 114(2):9. PubMed ID: 30656501
[TBL] [Abstract][Full Text] [Related]
19. Cell Therapy Trials in Congenital Heart Disease.
Oh H
Circ Res; 2017 Apr; 120(8):1353-1366. PubMed ID: 28408455
[TBL] [Abstract][Full Text] [Related]
20. Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation.
Gallet R; de Couto G; Simsolo E; Valle J; Sun B; Liu W; Tseliou E; Zile MR; Marbán E
JACC Basic Transl Sci; 2016; 1(1-2):14-28. PubMed ID: 27104217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
